296 related articles for article (PubMed ID: 19249061)
21. Measuring brain atrophy in multiple sclerosis.
De Stefano N; Battaglini M; Smith SM
J Neuroimaging; 2007 Apr; 17 Suppl 1():10S-15S. PubMed ID: 17425728
[TBL] [Abstract][Full Text] [Related]
22. Grey matter pathology in multiple sclerosis.
Geurts JJ; Barkhof F
Lancet Neurol; 2008 Sep; 7(9):841-51. PubMed ID: 18703006
[TBL] [Abstract][Full Text] [Related]
23. Diffusely abnormal white matter in chronic multiple sclerosis: imaging and histopathologic analysis.
Seewann A; Vrenken H; van der Valk P; Blezer EL; Knol DL; Castelijns JA; Polman CH; Pouwels PJ; Barkhof F; Geurts JJ
Arch Neurol; 2009 May; 66(5):601-9. PubMed ID: 19433660
[TBL] [Abstract][Full Text] [Related]
24. Measurement of brain and spinal cord atrophy by magnetic resonance imaging as a tool to monitor multiple sclerosis.
Bakshi R; Dandamudi VS; Neema M; De C; Bermel RA
J Neuroimaging; 2005; 15(4 Suppl):30S-45S. PubMed ID: 16385017
[TBL] [Abstract][Full Text] [Related]
25. Neuroimaging in multiple sclerosis.
Zivadinov R; Cox JL
Int Rev Neurobiol; 2007; 79():449-74. PubMed ID: 17531854
[TBL] [Abstract][Full Text] [Related]
26. Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter.
Vercellino M; Masera S; Lorenzatti M; Condello C; Merola A; Mattioda A; Tribolo A; Capello E; Mancardi GL; Mutani R; Giordana MT; Cavalla P
J Neuropathol Exp Neurol; 2009 May; 68(5):489-502. PubMed ID: 19525897
[TBL] [Abstract][Full Text] [Related]
27. The relation between MRI measures of inflammation and neurodegeneration in multiple sclerosis.
Inglese M; Benedetti B; Filippi M
J Neurol Sci; 2005 Jun; 233(1-2):15-9. PubMed ID: 15949493
[TBL] [Abstract][Full Text] [Related]
28. Rate of brain atrophy in benign vs early multiple sclerosis.
Gauthier SA; Berger AM; Liptak Z; Duan Y; Egorova S; Buckle GJ; Glanz BI; Khoury SJ; Bakshi R; Weiner HL; Guttmann CR
Arch Neurol; 2009 Feb; 66(2):234-7. PubMed ID: 19204160
[TBL] [Abstract][Full Text] [Related]
29. Visualizing the cause of gray matter atrophy in multiple sclerosis.
Richert ND; Kraft E; Stüve O
Arch Neurol; 2009 Feb; 66(2):159-60. PubMed ID: 19204151
[No Abstract] [Full Text] [Related]
30. In vivo MR imaging of hippocampal lesions in multiple sclerosis.
Roosendaal SD; Moraal B; Vrenken H; Castelijns JA; Pouwels PJ; Barkhof F; Geurts JJ
J Magn Reson Imaging; 2008 Apr; 27(4):726-31. PubMed ID: 18302199
[TBL] [Abstract][Full Text] [Related]
31. Magnetic resonance imaging surrogates of multiple sclerosis pathology and their relationship to central nervous system atrophy.
Meier DS; Weiner HL; Khoury SJ; Guttmann CR
J Neuroimaging; 2004 Jul; 14(3 Suppl):46S-53S. PubMed ID: 15228759
[TBL] [Abstract][Full Text] [Related]
32. Magnetic resonance techniques to quantify tissue damage, tissue repair, and functional cortical reorganization in multiple sclerosis.
Filippi M; Agosta F
Prog Brain Res; 2009; 175():465-82. PubMed ID: 19660674
[TBL] [Abstract][Full Text] [Related]
33. What you see depends on how you look: Gray matter lesions in multiple sclerosis.
Chard DT; Miller DH
Neurology; 2009 Sep; 73(12):918-9. PubMed ID: 19692676
[No Abstract] [Full Text] [Related]
34. Accumulation of cortical lesions in MS: relation with cognitive impairment.
Roosendaal SD; Moraal B; Pouwels PJ; Vrenken H; Castelijns JA; Barkhof F; Geurts JJ
Mult Scler; 2009 Jun; 15(6):708-14. PubMed ID: 19435749
[TBL] [Abstract][Full Text] [Related]
35. Magnetic resonance evidence of cortical onset of multiple sclerosis.
Calabrese M; Gallo P
Mult Scler; 2009 Aug; 15(8):933-41. PubMed ID: 19667021
[TBL] [Abstract][Full Text] [Related]
36. Update on the relationships between neuropsychological dysfunction and structural MRI in multiple sclerosis.
Tekok-Kilic A; Benedict RH; Zivadinov R
Expert Rev Neurother; 2006 Mar; 6(3):323-31. PubMed ID: 16533137
[TBL] [Abstract][Full Text] [Related]
37. Cortical atrophy and personality in multiple sclerosis.
Benedict RH; Hussein S; Englert J; Dwyer MG; Abdelrahman N; Cox JL; Munschauer FE; Weinstock-Guttman B; Zivadinov R
Neuropsychology; 2008 Jul; 22(4):432-41. PubMed ID: 18590355
[TBL] [Abstract][Full Text] [Related]
38. Is it clinically relevant to repair focal multiple sclerosis lesions?
Comi G
J Neurol Sci; 2008 Feb; 265(1-2):17-20. PubMed ID: 17950360
[TBL] [Abstract][Full Text] [Related]
39. Gray matter damage in multiple sclerosis: Impact on clinical symptoms.
van Munster CE; Jonkman LE; Weinstein HC; Uitdehaag BM; Geurts JJ
Neuroscience; 2015 Sep; 303():446-61. PubMed ID: 26164500
[TBL] [Abstract][Full Text] [Related]
40. Grey matter damage in multiple sclerosis: a pathology perspective.
Klaver R; De Vries HE; Schenk GJ; Geurts JJ
Prion; 2013; 7(1):66-75. PubMed ID: 23324595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
